Who owns Conduit Pharmaceuticals?
- CUSIP Number: 20678x205
Tip: Access positions for across all investors
Analyze quarterly positions in Conduit Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Conduit Pharmaceuticals stock
Who bought or sold Conduit Pharmaceuticals this quarter?
There are no current stakeholders of Conduit Pharmaceuticals.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Conduit Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Goldman Sachs Group | Mar 2025 | 13k | $9.8k |
| Jpmorgan Chase & Co | Mar 2025 | 843.00 | $702.471900 |